1. 卢煜明 中国 香港中文大学 2013美国科学院院士;2022拉斯克奖;2023中国科学院院士 What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in ..
2. Ribas, Antoni 美国 University of California, Los Angeles 2020美国医学院院士 A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with B..
3. 黄晓军 中国 北京大学 2023中国工程院院士 Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of ..
4. 杨焕明 中国 中国科学院 中国科学院院士;2014美国科学院院士 Massively targeted evaluation of therapeutic CRISPR off-targets in cells
5. George M. Church 美国 Harvard Medical School 2011美国科学院院士;2012美国工程院院士 Massively targeted evaluation of therapeutic CRISPR off-targets in cells
6. 徐兵河 中国 中国医学科学院 2021中国工程院院士 Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response..
7. 曾益新 中国 国家卫生健康委员会 中国科学院院士 Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response..
8. 郑树森 中国 浙江大学 中国工程院院士 Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome
9. 徐兵河 中国 中国医学科学院 2021中国工程院院士 Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic ..
10. Jennifer A,Wargo 美国 University of Texas MD Anderson Cancer Center 2023美国医学院院士 Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small C..
11. Kenneth W,Kinzler 美国 Johns Hopkins University 2015美国医学院院士;2016美国科学院院士 The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cance..
12. Bert,Vogelstein 美国 Johns Hopkins University 1992美国科学院院士;2001美国医学院院士 The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cance..
13. Michael,Ohh 加拿大 University of Toronto Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome
14. Jarushka,Naidoo 美国 Johns Hopkins University Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrat..
15. 王洁 中国 中国医学科学院 Real-world outcomes of chemoimmunotherapy and selective RET inhibitors in Chinese patients with RET ..
16. 李金明 中国 北京医院 Enhancing the quality of panel-based tumor mutation burden assessment: a comprehensive study of real..
17. Kyoichi,Kaira 日本 Saitama Medical University The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cance..
18. 宋勇 中国 东部战区总医院 Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic ..
19. Marcello,Tiseo 意大利 University of Hospital PARMA Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular ge..
20. 侯长军 中国 重庆大学 教授 博导 CRISPR/Cas12a and primer-assisted rolling circle amplification integrated ultra-sensitive dual-signa..